Fatty acid synthase expression in melanoma

Journal of Cutaneous Pathology

Volumn 30, Issue 1, 2003, Pages 23-28

  Innocenzi, D ^a   Alo P L ^b   Balzani, A ^c   Sebastiani, V ^c   Silipo, V ^c   La Torre, G ^c   Ricciardi, G ^c   Bosman, C ^c   Calvieri, S ^c  

^a Department of Dermatology ^*  (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; FATTY ACID; FATTY ACID SYNTHASE;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; NEVUS; OVARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; SKIN METASTASIS;

EID: 0037258555     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.300104.x     Document Type: Article

References (30)

1. Armstrong BK. Descriptive epidemiology of skin cancers. In: Grob, JJ, Stern, RS, MacKie, RM, Weinstock, WA., eds. Epidemiology, causes and prevention of skin diseases. Oxford, UK: Blackwell Science, 1997; 41.
2. Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: where do we stand? Eur J Dermatol 2000; 10: 71.
3. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839.
4. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between population. Br J Cancer 2000; 82: 1887.
5. Ronan SG, Han MC, Das Gupta TK. Histologic prognostic indicator in cutaneous malignant melanoma. Semin Oncol 1988; 15: 558.
6. Clark WH, Elder DE, Dupont G et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893.
7. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996; 78: 427.
8. Wilentz RE, Witters LA, Pizer ES. Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Pediatr Dev Pathol 2000; 3: 525.
9. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000; 16: 202.
10. Paulauskis JD, Sul HS. Hormonal regulation of mouse fatty acid synthase gene trascription in liver. J Biol Chem 1989; 264: 574.
11. Chalbos D, Joyeux C, Galtier F et al. Regulation of fatty acid synthase by progesterone in normal and tumoral human mammary gland. Rev Esp Fisiol 1990; 46: 43.
12. Wagle S, Bui A, Shuman H et al. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung. Am J Physiol 1999; 277: L381.
13. Piyathilake CJ, Frost AR, Manne U et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000; 31: 1068.
14. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR, Kurman RJ. Fatty acid synthase expression in endometrial carcinoma. Cancer 1998; 83: 528.
15. Gansler TS, Hardman W III, Hunt DA, Schaffel S, Hennigar RA. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997; 28: 686.
16. Alò PL, Visca P, Framarino ML et al. Immunohistochemical study of fatty acid synthase in ovarian neoplasm. Oncol Report 2000; 7: 1383.
17. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of fatty acid synthase (OA519) as a predictor of progression of prostate cancer. Hum Pathol 1996; 27: 917.
18. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res 1997; 57: 1086.
19. Chalbos D, Joyeux C, Galtier F, Rochefort H. Progestin induced fatty acid synthetase in human mammary tumors: from molecular biology to clinical studies. J Steroid Biochem Mol Biol 1992; 43: 223.
20. Alò PL, Visca P, Marci A et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 1996; 77: 474.
21. Rashid A, Pizer ES, Moga M et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997; 150: 201.
22. Visca P, Alò PL, Del Nonno F et al. Immunohistochemical expression of fatty acid synthase, apoptotic regulating genes, proliferating factors and ras protein product in colorectal adenomas, carcinomas and adjacent non-neoplastic mucosa. Clin Cancer Res 1999; 5: 4111.
23. Kuhajda FP, Jenner K, Wood FD et al. Fatty acid synthase: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994; 91: 6379.
24. Pizer ES, Wood FD, Heine HS et al. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 1996; 56: 1189.
25. Uchiyama N, Yamamoto A, Kameda K, Yamaguchi H, Ito M. The activity of fatty acid synthase of epidermal keratinocytes is regulated in the lower stratum spinosum and the stratum basale by local inflammation rather than by circulating hormones. J Dermatol Sci 2000; 24: 134.
26. Osborne EJ, Hutchinson PE. Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol 2001; 144: 476.
27. Ostmeier H, Fuchs B, Otto F et al. Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? Cancer 1999; 85: 2391.
28. Hieken TJ, Ronan SG, Farolan M, Shilkaitis AL, Das Gupta TK. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer 1999; 85 (2): 375.
29. Krontiras H, Roye GD, Beenken SE et al. Fatty acid synthase expression is increased in neoplastic lesion of oral tongue. Head Neck 1999; 21: 325.
30. Wang Y, Kuhajda FP, Sokoll LJ, Chan DW. Two-site Elisa for the quantitative determination of fatty acid synthase. Clin Chim Acta 2001; 304: 107.